A/Prof Johan Verjans is a clinician-scientist at the Royal Adelaide Hospital with a research focus on cross-disciplinary translational research. In his role as a deputy director at the Australian Institute for Machine Learning (AIML), a world-renowned institute in Machine Learning, and as platform leader AI at SAHMRI, he combines experience in molecular medicine and clinical research with vast experience working with engineers for advanced imaging techniques, and computer scientists to apply machine learning to medical problems to translate research into the clinic.
He graduated in medicine from Maastricht University (MD-PhD) after being awarded the DiPalma Fellowship to work with the renowned Prof Narula in Philadelphia and UC Irvine. During cardiology training, he was awarded a prestigious Rubicon Fellowship by the Dutch Science Foundation to complete a post-doctoral fellowship at MGH/Harvard Medical School, followed by a clinician-scientist award at the University Medical Centre Utrecht during his cardiology training. He was recruited by the University of Adelaide in 2017 and was in 2022 recipient of the University’s Future Industry Making Fellowship.
Since then, he has formed the Medical Machine Learning group at AIML and used his combined clinical, biomedical and technical expertise to lead a rapidly growing group of clinicians, biomedical researchers and computer scientists with the objective of making the University of Adelaide a global leader in AI in Healthcare. The group has grown to over 25 members, won international technology challenges and has contracts with pharma and technology companies such as GSK, Roche, Siemens Healthineers and Medtronic. A testament to their diligence, their institute was distinguished as the AI Centre in Medicine of the Year in 2022 by the AI Global Summit.
A significant achievement is that his team won the global Medical VQA challenge (NIH), which used precursors of the current ChatGPT.